Limited usefulness of intermittent nitroglycerin patches in stable angina.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of the American College of Cardiology

• Publication date

  1989-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0735-1097(89)90521-4PMID 2492322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval.

  1988cited by this paper
• Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.

  1988cited by this paper
• Prevention of tolerance to nitroglycerin patches by overnight removal.

  1987cited by this paper
• Nitrate therapy in stable angina pectoris.

  1987cited by this paper
• Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application.

  1987cited by this paper
• Features of the exercise test that reflect the activity of ischemic heart disease out of hospital.

  1986cited by this paper
• Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.

  1986cited by this paper
• A multicenter trial of transdermal nitroglycerin in exercise-induced angina: individual antianginal response after repeated administration.

  1986cited by this paper
• Effect of a new transdermal therapeutic system containing nitroglycerin on exercise capacity in patients with angina pectoris.

  1985cited by this paper
• Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.

  1985cited by this paper
• Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris.

  1985cited by this paper
• Transdermal Nitroglycerin in Angina Pectoris

  1984cited by this paper
• Comparative evaluation of the effect of two doses of Nitroderm TTS on exercise-related parameters in patients with angina pectoris.

  1984cited by this paper
• Post-Marketing Surveillance of the Transiderm-Nitro Patch in General Practice

  1984cited by this paper
• Antianginal effects of nitroglycerin patches.

  1984cited by this paper
• Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial.

  1984cited by this paper
• Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.

  1984cited by this paper
• The Mechanisms of Nitroglycerin Action: Stenosis Vasodilatation as a Major Component of the Drug Response

  1981cited by this paper
• Nonatheromatous Ischemic Heart Disease following Withdrawal from Chronic Industrial Nitroglycerin Exposure

  1972cited by this paper
• Cardiovascular survey methods.

  1969cited by this paper

• Nitrate-functionalized patch confers cardioprotection and improves heart repair after myocardial infarction via local nitric oxide delivery

  2021cites this paper
• Transdermal Nitroglycerin but Fails to Prevent Silent Ischemh

  2016cites this paper
• Nitrates for stable angina: a systematic review and meta-analysis of randomized clinical trials.

  2011cites this paper
• [Transdermal nitroglycerin systems with continuous and discontinuous drug release. A comparison of the anti-ischemic and hemodynamic acute and long-term effects].

  2008cites this paper
• Long-term nitrate therapy after acute myocardial infarction does not improve or aggravate prognosis.

  2007cites this paper
• Inhibition of Nitrate Tolerance without Reducing Vascular Response during Eccentric Dosing of Nitrates

  2006cites this paper
• Nitrates: Why and how should they be used today?

  2005cites this paper
• Intermit tent Nitroglycerin: or Continuous Transdermal Still an Issue, or Is the Case Closed?

  2004cites this paper
• Eccentric dosing of nitrates does not increase cardiac events in patients with healed myocardial infarction.

  2004cites this paper
• Safety of nitrate withdrawal in angina-free and hemodynamically stable patients with coronary artery disease.

  2003cites this paper
• Dérivés nitrés

  2001cites this paper
• Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity.

  2000cites this paper
• Nitrate therapy for stable angina pectoris.

  1999cites this paper
• N ITRATE T HERAPY FOR S TABLE A NGINA P ECTORIS

  1998cites this paper
• Nitrate therapy in stable angina pectoris.

  1998cites this paper
• Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).

  1997cites this paper
• Book Review

  1997cites this paper
• Nitrates Updated

  1997cites this paper
• North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management of stable angina

  1996cites this paper
• North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management angina. North of England Stable Angina Guideline Development Group.

  1996cites this paper
• Nitrate tolerance: Current concepts concerning mechanisms and implications for therapy

  1996cites this paper
• Potential problems with intermittent nitrate therapy.

  1996cites this paper
• Intermittent or continuous transdermal nitroglycerin: Still an issue, or Is the case closed?

  1996cites this paper
• Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.

  1995cites this paper
• Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.

  1995cites this paper
• Risk of rebound phenomenon during nitrate withdrawal.

  1994cites this paper
• Ointments and transdermal nitroglycerin patches for stable angina pectoris

  1994cites this paper
• Efficacy of long-term administration of transdermal nitroglycerin in asymptomatic patients with effort-induced silent myocardial ischemia.

  1994cites this paper
• Lack of Pharmacologic Tolerance and Rebound Angina Pectoris during Twice-Daily Therapy with Isosorbide-5-Mononitrate

  1994cites this paper
• Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker.

  1993cites this paper
• Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.

  1993cites this paper
• Transdermal nitroglycerin reduces the frequency of anginal attacks but fails to prevent silent ischemia.

  1993cites this paper
• Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina.

  1992cites this paper
• Acute and long-term effects on myocardial ischemia of intermittent and continuous transdermal nitrate therapy in stable angina.

  1992cites this paper
• An update on nitrate tolerance: can it be avoided?

  1992cites this paper
• Role of nitrates in angina pectoris.

  1992cites this paper
• Placebo effect of nitrate monotherapy for myocardial ischemia.

  1992cites this paper
• Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.

  1992cites this paper
• Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate.

  1992cites this paper
• Nitrate therapy: is there an optimal substance and formulation?

  1991cites this paper
• Nitrate: Warum und wie sie heute eingesetzt werden sollten

  1991cites this paper
• Transdermal nitroglycerin. Does it really work in the treatment of angina?

  1991cites this paper
• Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris.

  1991cites this paper
• β-adrenoceptor antagonists and antianginal drugs

  1991cites this paper
• Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators.

  1991cites this paper
• The day-long antianginal effectiveness of nitroglycerin patches. A double-blind study using dose-titration.

  1991cites this paper
• A practical guide to nitrate use.

  1991cites this paper
• Attenuation of nitrate effect during an intermittent treatment regimen and the time course of nitrate tolerance.

  1991cites this paper
• Nitrate tolerance in angina pectoris: effect of transdermal nitroglycerin with a four-hour nitrate-free interval.

  1991cites this paper
• Organic nitrate esters: clinical use and mechanisms of actions.

  1991cites this paper
• Transdermal Nitroglycerin

  1991cites this paper
• Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: a multicentric study. The Collaborative Nitro Group.

  1991cites this paper
• [Not Available].

  1991cites this paper
• Transdermal Nitroglycerin (Glyceryl Trinitrate

  1990cites this paper
• Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.

  1990cites this paper
• Clinical benefit of transdermal glyceryl trinitrate when used with an eight hour patch-free period.

  1990cites this paper
• What causes tolerance to nitroglycerin? The 100 year old mystery continues.

  1990cites this paper
• Sustained High‐Dose Nitroglycerin Transcutaneous Patch Therapy in Angina Pectoris: Evidence for Attenuation of Effect Over Time

  1989cites this paper
• Transdermal nitroglycerin.

  1989cites this paper
• Interval therapy to avoid nitrate tolerance: paradise regained?

  1989cites this paper
• Lack of rebound during intermittent transdermal

  year unknowncites this paper
• Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate

  year unknowncites this paper
• BOOK REVIEW

  year unknowncites this paper